Veterans HOPE Act

Key Points

• The bill requires the VA to complete a comprehensive review of all veteran opioid overdose deaths from the past five years within 18 months. This review must include demographic breakdowns by age, sex, race, and ethnicity to identify which veteran groups face the highest risk.
• The VA must catalog all medications found in the bodies of deceased veterans at the time of death, with special attention to black box warning drugs, off-label prescriptions, psychotropic medications, and cases where veterans were on multiple drugs at once.
• The review will examine whether veterans who died had combat experience or trauma, including military sexual trauma, traumatic brain injury, and PTSD. This data could reveal how service-related conditions contribute to overdose risk.
• Congress notes that veteran overdose deaths are increasingly driven by heroin and synthetic opioids like fentanyl rather than VA prescriptions. VHA patients are seven times more likely to have an opioid use disorder than commercially insured patients, and the bill pushes prevention efforts beyond just prescription monitoring.
• The VA must submit a public report to Congress within 45 days of completing the review, along with a briefing to both Veterans' Affairs committees. The report must include recommendations to improve veteran safety and reduce overdose rates.